Treatment success rate for patients treated for MDR-TB in Burkina Faso
Burkina Faso: Treatment success rate for patients treated for MDR-TB was 69.0% in 2022. ▲ Rising
Treatment success rate for patients treated for MDR-TB in Burkina Faso, 2007–2022
Source: World Health Organization, Global Health Observatory.
Analysis
Burkina Faso recorded 69.0% for treatment success rate for patients treated for mdr-tb in 2022.
That represents a change of up 15.0% on the previous year and up 19.0% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Burkina Faso peaked at 75.0% in 2008 and was at its lowest, 40.0%, in 2007.
That places Burkina Faso 101st out of 163 countries with data for 2022, putting it in the middle of the range.
The long-run direction has been consistently rising across the 16 years of available data.
Treatment success rate for patients treated for MDR-TB in Burkina Faso, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 40.0% | — |
| 2008 | 75.0% | +87.5% |
| 2009 | 50.0% | -33.3% |
| 2010 | 63.0% | +26.0% |
| 2011 | 73.0% | +15.9% |
| 2012 | 58.0% | -20.5% |
| 2013 | 62.0% | +6.9% |
| 2014 | 68.0% | +9.7% |
| 2015 | 68.0% | +0.0% |
| 2016 | 63.0% | -7.4% |
| 2017 | 57.0% | -9.5% |
| 2018 | 72.0% | +26.3% |
| 2019 | 69.0% | -4.2% |
| 2020 | 75.0% | +8.7% |
| 2021 | 60.0% | -20.0% |
| 2022 | 69.0% | +15.0% |
Burkina Faso compared with similar countries
- Burkina Faso's 69.0% is below the median for low income countries, which is 75.0%, 92% of the median. (25 countries reporting)
- Burkina Faso's 69.0% is below the median for Sub-Saharan Africa, which is 76.0%, 91% of the median. (46 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 55.0% | 40.0% | 75.0% | 3 |
| 2010s | 65.3% | 57.0% | 73.0% | 10 |
| 2020s | 68.0% | 60.0% | 75.0% | 3 |
Countries ranked near Burkina Faso
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,142 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13,085 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 0.8681 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0693 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7133 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Burkina Faso?
- Treatment success rate for patients treated for mdr-tb in Burkina Faso was 69.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Burkina Faso?
- The highest recorded value was 75.0% in 2008.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Burkina Faso?
- The lowest recorded value was 40.0% in 2007.
- How does Burkina Faso rank for treatment success rate for patients treated for mdr-tb?
- Burkina Faso ranks 101st out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Burkina Faso?
- Over the last ten years it is up 19.0%. The long-run trend across the full record is rising.
- Where does this Burkina Faso data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).